Close Brothers Group plc
Close Brothers Group plc (CS3.F) Financial Performance & Income Statement Overview
Analyze Close Brothers Group plc (CS3.F) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Close Brothers Group plc (CS3.F) Income Statement & Financial Overview
Analyze Close Brothers Group plc’s CS3.F earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $819.30M | $469.00M | $811.35M | $723.85M |
| Cost of Revenue | $0.00 | -$325.60M | $0.00 | $0.00 |
| Gross Profit | $819.30M | $794.60M | $811.35M | $723.85M |
| Gross Profit Ratio | $1.00 | $1.69 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $802.60M | $374.60M | $0.00 | $0.00 |
| Operating Expenses | $401.30M | $375.20M | $382.68M | $355.91M |
| Total Costs & Expenses | $787.80M | $375.20M | $694.26M | $710.58M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $57.60M | -$94.40M | $65.96M | $58.64M |
| EBITDA | $89.10M | -$600000.00 | $65.96M | $58.64M |
| EBITDA Ratio | $0.11 | -$0.001 | $0.08 | $0.08 |
| Operating Income | $31.50M | $94.40M | -$1.00 | $0.00 |
| Operating Income Ratio | $0.04 | $0.20 | -$0.00 | $0.00 |
| Other Income/Expenses (Net) | $16.70M | -$600000.00 | $117.09M | -$354.67M |
| Income Before Tax | $48.20M | $93.80M | $117.09M | $13.27M |
| Income Before Tax Ratio | $0.06 | $0.20 | $0.14 | $0.02 |
| Income Tax Expense | $16.60M | $25.00M | $32.22M | $3.74M |
| Net Income | $31.60M | $68.80M | $84.87M | $9.53M |
| Net Income Ratio | $0.04 | $0.15 | $0.10 | $0.01 |
| EPS | $0.21 | $0.46 | $0.57 | $0.06 |
| Diluted EPS | $0.21 | $0.46 | $0.57 | $0.06 |
| Weighted Avg Shares Outstanding | $149.60M | $149.60M | $173.78M | $169.45M |
| Weighted Avg Shares Outstanding (Diluted) | $149.60M | $149.60M | $174.58M | $170.24M |
The company's financials show resilient growth, with revenue advancing from $723.85M in Q2 2023 to $819.30M in Q4 2024. Gross profit remained healthy with margins at 100% in Q4 2024 compared to 100% in Q2 2023. Operating income hit $31.50M last quarter, sustaining a consistent 4% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $89.10M. Net income dropped to $31.60M, while earnings per share reached $0.21. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan